Overview
A Comparative study Between Ultrasound guided Interscalene Block and Combined Ultrasound guided suprascapular and axillary nerve blocks for proximal humerus fracture Surgeries.
The aim of this study is to investigate whether (Suprascapular nerve block) and (Axillary nerve block) are effective in providing analgesia for shoulder surgery as an (Interscalene block), while minimizing the occurrence of hemi-diaphragmatic paralysis. We hypothesized that analgesia with a (Suprascapular nerve block and Axillary nerve block) would be noninferior compared with patients receiving an interscalene block and the incidence of hemi-diaphragmatic paralysis would be significantly lower with (Suprascapular nerve block and Axillary nerve block) in proximal humerus fracture surgeries.
Description
A Comparative study Between Ultrasound guided Interscalene Block and Combined Ultrasound guided suprascapular and axillary nerve blocks for proximal humerus fracture Surgeries.
The aim of this study is to investigate whether (Suprascapular nerve block) and (Axillary nerve block) are effective in providing analgesia for shoulder surgery as an (Interscalene block), while minimizing the occurrence of hemi-diaphragmatic paralysis. We hypothesized that analgesia with a (Suprascapular nerve block and Axillary nerve block) would be noninferior compared with patients receiving an interscalene block and the incidence of hemi-diaphragmatic paralysis would be significantly lower with (Suprascapular nerve block and Axillary nerve block) in proximal humerus fracture surgeries.
Eligibility
Inclusion Criteria:
- Patients American Society of anesthesiologists' physical status (ASA) I to II.
- Aged 18 to 65 years.
- Both sexes.
- Patients scheduled for proximal humerus fracture surgeries.
Exclusion Criteria:
- Patient refusal
- ASA physical status III or more.
- Patients with known allergy to any of the study drugs.
- Infection at the site of injection.
- Patients with history of cardiovascular disease.
- Patients with renal disease.
- Patients with hepatic disease.
- Patients with neuromuscular disease.
- Presence of any coagulopathy.
- Chronic opioid, gabapentin or pregabalin use.
- Patients with history of any psychiatric disorder.
- BMI more than 35 kg/m2.